Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 3
2010 1
2011 2
2013 2
2014 2
2016 1
2020 2
2021 1
2022 3
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial.
Hall PS, Swinson D, Cairns DA, Waters JS, Petty R, Allmark C, Ruddock S, Falk S, Wadsley J, Roy R, Tillett T, Nicoll J, Cummins S, Mano J, Grumett S, Stokes Z, Kamposioras KV, Chatterjee A, Garcia A, Waddell T, Guptal K, Maisey N, Khan M, Dent J, Lord S, Crossley A, Katona E, Marshall H, Grabsch HI, Velikova G, Ow PL, Handforth C, Howard H, Seymour MT; GO2 Trial Investigators. Hall PS, et al. JAMA Oncol. 2021 Jun 1;7(6):869-877. doi: 10.1001/jamaoncol.2021.0848. JAMA Oncol. 2021. PMID: 33983395 Free PMC article. Clinical Trial.
COVID-19 Vaccination in Cancer Patients: A Review Article.
Mekkawi R, Elkattan BA, Shablak A, Bakr M, Yassin MA, Omar NE. Mekkawi R, et al. Among authors: shablak a. Cancer Control. 2022 Jan-Dec;29:10732748221106266. doi: 10.1177/10732748221106266. Cancer Control. 2022. PMID: 36066031 Free PMC article. Review.
5T4 as a target for immunotherapy in renal cell carcinoma.
Elkord E, Shablak A, Stern PL, Hawkins RE. Elkord E, et al. Among authors: shablak a. Expert Rev Anticancer Ther. 2009 Dec;9(12):1705-9. doi: 10.1586/era.09.152. Expert Rev Anticancer Ther. 2009. PMID: 19954280 No abstract available.
High-dose interleukin2 - a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome.
Chow S, Galvis V, Pillai M, Leach R, Keene E, Spencer-Shaw A, Shablak A, Shanks J, Liptrot T, Thistlethwaite F, Hawkins RE. Chow S, et al. Among authors: shablak a. J Immunother Cancer. 2016 Oct 18;4:67. doi: 10.1186/s40425-016-0174-5. eCollection 2016. J Immunother Cancer. 2016. PMID: 27777776 Free PMC article.
19 results